Follow-Up – Fall 2017

Research doesn’t stop when we report it. Here are updates on past UConn Health Journal stories:

UConn Center on Aging

The UConn Center on Aging is one of 14 planned study sites for the TAME (Targeting Aging with Metformin) clinical trial led by Albert Einstein College of Medicine’s Dr. Nir Barzilai and colleagues from Wake Forest School of Medicine. The researchers hope to test the ability of diabetes drug metformin to slow development of aging-related conditions such as cancer, dementia, and cardiovascular diseases.

Childhood Anxiety Research

Anxiety in children may need to be treated as a chronic condition that requires regular follow-up, reported UConn Health psychologist Golda Ginsburg at this year’s Anxiety and Depression Association of America conference. The results are from a study that followed 488 children and adolescents with anxiety who were randomly assigned to get cognitive behavioral therapy (CBT), an antidepressant, CBT and an antidepressant, or a placebo. Remission rates five years after treatment were the same, no matter the treatment.

UConn Health’s Dr. Anthony Alessi has treated athletes from boxers to UConn student-athletes to average Joes for decades. Through it all, he’s had a unique view into the way we treat and prevent head trauma in sports.